Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12401 - 12425 of 15131 in total
Experimental
Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).
Investigational
Matched Description: … Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety …
Experimental
Allosamidin exhibits extremely potent inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and can be utilized as potent antifungal agent.
Experimental
Matched Description: … inhibitory activity against chitinases from a number of sources, particularly from Candida albicans, and
Experimental
Tetomilast has been used in trials studying the treatment of Crohn Disease, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease.
Investigational
Matched Description: … Tetomilast has been used in trials studying the treatment of Crohn Disease, Colitis, Ulcerative, and
Tezosentan is an intravenous endothelin receptor A/B antagonist. Tezosentan was initially developed for vasodilation in patients with acute heart failure but studies have shown that it does not assist in the treatment of dyspnea or prevent cardiovascular events.
Investigational
Displaying drugs 12401 - 12425 of 15131 in total